Diet and exercise coaches are the future of preventing T2D in patients with overweight or obesity.
Read More »Mental Disorders Complicate the Treatment of Patients with Diabetes
Individuals with mental health disorders have an increased risk for type 2 diabetes and premature death; modifiable risk factors affected by antipsychotics are obesity, insulin resistance, diabetes, and dyslipidemia.
Read More »ADA 81st Symposium: Comparison of Dexcom G6 Continuous Glucose Monitoring Performance between Abdomen and Upper Arm Placement
Alternative site placement of continuous glucose monitor device is assessed in the hospital setting.
Read More »ADA 2021: Finerenone in the Chronic Kidney Disease and Diabetes Population
Finerenone is a mineralocorticoid receptor antagonist indicated for chronic kidney disease (CKD) with type 2 diabetes. Does the use of insulin affect its performance against kidney and cardiovascular issues?
Read More »ADA 2021: Lowering of Blood Pressure and Pulse Rate by Switching from DPP-4 Inhibitor to Luseogliflozin in Patients with T2D and Hypertension
Researchers investigate the changes in ambulatory blood pressure using the antidiabetic drug in patients with type 2 diabetes and hypertension.
Read More »Greater Weight Loss Found With SGLT-2 Inhibitors Than GLP-1 RAs in Patients with T2D
Contrary to previous studies, new research finds SGLT-2i more effective for weight loss than GLP-1 RAs as add-on therapy to Metformin.
Read More »ADA 2021: Dasiglucagon and the Effects Among Various Demographics
Dasiglucagon is a glucagon analog stable in an aqueous formulation with FDA approval for severe hypoglycemia use. The target population is patients with diabetes who are six years of age and older, but how effective is it among other subgroups?
Read More »Dosing Error Due to Misinterpretation
When reviewing the medical record of a hospital patient before meeting with her for a diabetes consult, I noted that the doctor had ordered 46 units of Lantus to be given daily at bedtime....
Read More »Here We Go Again: The Low-Carb vs. High-Carb and Training Debate
By Sheri Colberg, PhD
Who knew I'd be talking about carbohydrate intake and being active for the third time this year, but here we go again! Unfortunately, a lot of confusion still exists related to the practice known as "carb loading" as well. Do you need to do it? Should you? How do you know?
Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval
With the introduction of this new biosimilar insulin, patients with diabetes will have the opportunity to have easier and broader access to insulin therapy, and a more affordable option than those already on the market.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.